Find University Hospitals Doctors

Karla Madalin, MD

Karla Madalin, MD



33 Ratings 10 Reviews



Not Accepting New Patients

Languages Spoken


Office Locations

Patient Experience Reviews

4.5 out of 5

33 Ratings

Patient Comments (10)

Reviewed On 4/1/2022
Good experience always with this doctor.

Reviewed On 10/1/2021
I was very disappointed in my last appointment with Dr. Madelin and I may not be returning.

Reviewed On 10/1/2021
Everyone was so friendly including the doctor. I appreciate this very much. I want them to feel like friends. That way I am more at ease.

Reviewed On 9/1/2021
Excellent doctor. I have followed her office to office for many years.

Reviewed On 8/1/2021
I feel there is an excellent exchange with Dr. Madalin. She asks good questions, allows me to respond and offers her expertise.

Reviewed On 8/1/2021
very good

Reviewed On 7/1/2021
Dr. Madelin listened to my questions and input and provided reasonable feedback

Reviewed On 7/1/2021
excellent Dr and staff

Reviewed On 6/1/2021
Very good informative experience with Dr. Madeline.

Reviewed On 6/1/2021
The doctor was very warm and caring and explained why I needed more tests.

Board Certifications

  • Neurology - American Board of Psychiatry and Neurology


Research Fellowship | Neurology
Neurology - Cleveland Clinic (1988 - 1990)

Residency | Neurology
Neurology - Cleveland Clinic (1986 - 1988)

Residency | Neurological Surgery
Neurological Surgery - Cleveland Clinic (1983 - 1986)

Internship | Neurological Surgery
Neurological Surgery - Cleveland Clinic (1982 - 1983)

Medical Education
Baylor College Of Medicine - Texas Medical Center (1981)

University Of Cincinnati (1978)

Industry Relationships

University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.

UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.

View UH’s policy (PDF) on practitioner-industry relationships.

As of December 31, 2016, Karla Madalin did not disclose any Outside Relationships with Industry.